Antigenic Recognition by the Brain: The Brain as an Immunocompetent Organ

New Insights to Neuroimmune Biology

Volumn , Issue , 2010, Pages 145-159

  Berczi, Istvan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882375267     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384691-4.00007-9     Document Type: Chapter

References (79)

1. AM Silverstein (1993) The history of immunology. WE Paul,(Eds) Fundamental immunology New York: Raven Press 31-41.
2. CA Janeway Jr, P Travers, M Walport and M Shlomchik (2005) Immunobiology. 6th ed. New York and London: Garland Science, Taylor and Francis Group
3. I Berczi (2007) Integration and regulation of higher organisms by the neuroimmune supersystem. Int J Integr Biol 1(3), 216-231.
4. JE Blalock (1984) The immune system as a sensory organ. J Immunol 132 167-170.
5. Y Ma, RL Haynes, RL Sidman and T Vartanian (2007) TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle 6(23), 2859-2868.
6. Downes CE, Crack PJ. The role of the toll-like receptors in neuropathology. In: Berczi I, Arnason BG, editors; Berczi I, series editor. The brain and host defence. Neuroimmune biology, vol. 9. Amsterdam: Elsevier.
7. M Nishimura and S Naito (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28(5), 886-892.
8. BB Mishra, PK Mishra and JM Teale (2006) Expression and distribution of toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 181(1–2), 46-56.
9. K Ohashi, V Burkart, S Flohe and H Kolb (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164(2), 558-561.
10. RM Vabulas, P Ahmad-Nejad, S Ghose, CJ Kirschning, RD Issels and H Wagner (2002) HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway. J Biol Chem 277(17), 15107-15112.
11. MF Tsan and B Gao (2004) Endogenous ligands of toll-like receptors. J Leukoc Biol 76(3), 514-519.
12. K Kariko, H Ni, J Capodici, M Lamphier and D Weissman (2004) mRNA is an endogenous ligand for toll-like receptor 3. J Biol Chem 279(13), 12542-12550.
13. GB Johnson, GJ Brunn, Y Kodaira and JL Platt (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J Immunol 168(10), 5233-5239.
14. T Wang, T Town, L Alexopoulou, JF Anderson, E Fikrig and RA Flavell (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10(12), 1366-1373.
15. Chow DA. Physiological activities of the natural immune system. In: Bertok L, Chow DA. editors; Berczi I, series editor. Natural immunity. Neuroimmune biology, vol. 5. Amsterdam: Elsevier; 2005. p. 311–29.
16. I Berczi, A Quintanar-Stephano and K Kovacs (2009) Neuroimmune regulation in immunocompetence, acute illness, and healing. Ann NY Acad Sci 1153 220-239.
17. Balabanov R. Immune aspects of the blood–brain barrier. In: Berczi I, Arnason BG, editors; Berczi I, series editor. The brain and host defence. Neuroimmune biology, vol. 9. Amsterdam: Elsevier.
18. Borlongan CV, Emerich DF. Choroid plexus and immune response of the brain. In: Berczi I, Arnason BG, editors; Berczi I, series editor. The brain and host defence. Neuroimmune biology, vol. 9. Amsterdam: Elsevier.
19. Nicholas K. Immunologic privilege and the brain. In: Berczi I, Arnason BG, editors; Berczi I, series editor. The brain and host defence. Neuroimmune biology, vol. 9. Amsterdam: Elsevier.
20. I Berczi (1998) Neuroendocrine response to endotoxin. Ann NY Acad Sci 851 411-415.
21. R Medzhitov and CA Janeway Jr (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296 298-300.
22. Berczi I, Bertok L, Chow D. Host defence: an interaction of neuroendocrine-, metabolic- and immune mechanisms in the interest of survival. In: Chow D, Bertok L, editors; Berczi I, series editor. Natural immunity. Neuroimmune biology, vol. 5. Amsterdam: Elsevier; 2005. p. 3–25.
23. Berczi I. Neuroendocrine regulation of natural immunity. In: Chow D, bertok L. editors, Berczi I, series editor. Natural immunity. Neuroimmune biology, vol. 5. Amsterdam: Elsevier; 2005. p. 215–62.
24. Jancsó G, Katona M, Horváth V, Sántha P, Nagy J. Sensory nerves as modulators of cutaneous immune reactions in health and disease. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2009. p. 3–36.
25. I Berczi and A Szentivanyi (2003) The immune-neuroendocrine circuitry. I Berczi, A Szentivanyi (Eds) The immune–neuroendocrine circuitry. History and progress. Neuroimmune biology vol. 3 Amsterdam: Elsevier 561-592.
26. Flo T, Aderen A. Pathogen recognition by toll-like receptors. In: Bertok L, Chow DA, editors; Berczi I, Szentivanyi A, series editors. Natural immunity. Neuroimmune biology, vol. 5. Amsterdam: Elsevier; 2005. p. 167–82.
27. Y Iwasaki, T Taguchi, M Nishiyama, M Asai, M Yoshida, M Kambayashi, et al. (2008) Lipopolysaccharide stimulates proopiomelanocortin gene expression in AtT20 corticotroph cells. Endocr J 55(2), 285-290.
28. SR Bornstein, CG Ziegler, AW Krug, W Kanczkowski, V Rettori, SM McCann, et al. (2006) The role of toll-like receptors in the immune-adrenal crosstalk. Ann NY Acad Sci 1088 307-318.
29. A Katsargyris, C Klonaris, A Alexandrou, AE Giakoustidis, I Vasileiou and S Theocharis (2009) Toll like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation? Expert Opin Ther Targets 13(4), 427-442.
30. L Shang, M Fukata, N Thirunarayanan, AP Martin, P Arnaboldi, D Maussang, et al. (2008) Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135(2), 529-538.
31. LK Curtiss and PS Tobias (2009) Emerging role of toll-like receptors in atherosclerosis. J Lipid Res 50(Suppl.), S340-S345.
32. SK Heo, HJ Yun, EK Noh, WH Park and SD Park (2008) LPS induces inflammatory responses in human aortic vascular smooth muscle cells via toll-like receptor 4 expression and nitric oxide production. Immunol Lett 120(1–2), 57-64.
33. E Pearlman, A Johnson, G Adhikary, Y Sun, HR Chinnery, T Fox, et al. (2008) Toll-like receptors at the ocular surface. Ocul Surf 6(3), 108-116.
34. EJ Peek, DF Richards, A Faith, P Lavender, TH Lee, CJ Corrigan, et al. (2005) Interleukin-10-secreting “regulatory” T cells induced by glucocorticoids and by beta-2-agonists. Am J Respir Cell Mol Biol 33 105-111.
35. I Berczi (1986) The influence of pituitary–adrenal axis on the immune system. I Berczi (Eds) Pituitary function and immunity Boca Raton, FL: Monograph published by CRC Press, Inc 49-131.
36. MC Morale, N Batticane, F Gallo, N Barden and B Marchetti (1995) Disruption of hypothalamic–pituitary–adrenocortical system in transgenic mice expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: effects on T cell trafficking and T cell responsiveness during postnatal development. Endocrinology 136(9), 3949-3960.
37. Blaettis CM. Fever as a host defense mechanism. In: Berczi I, Arnason BG, editors. The brain and host defence. Berczi I, Szentivanyi A, Series editors. Neuroimmune biology, vol. 9. Amsterdam: Elsevier [in this volume].
38. Pavlov VA, Ulloa L, Metz CN. Infection and sepsis. In: Berczi I, Arnason BG, editors; Berczi I, series editor. The brain and host defence. Neuroimmune biology, vol. 9. Amsterdam: Elsevier.
39. Korneva HA, Novikova, NS. Brain responses to antigenic challenges. In: Berczi I, Arnason BG, editors; Berczi I, series editor. The brain and host defence. Neuroimmune biology, vol. 9. Amsterdam: Elsevier.
40. Besedowsky HO, del Rey A. Processing of cytokine signals at CNS levels. Relevance for immune HPA–axis interaction. In: del Rey A, Chroousos G, Besedovsky HO, editors; Berczi I, Szentivanyi A, series editors. The hypothalamus–pituitary–adrenal axis. Neuroimmune biology, vol. 7. Amsterdam: Elsevier; 2008. p. 227–40.
41. Conti B, Tabarean I, Sanchez-Alavez M, Davis C, Brownell S, Behrens M, et al. Cytokines, their receptors and signal transduction in the brain. In: Phelps C, Korneva E. editors; Berczi I, Szentivanyi A, series editors. Cytokines and the brain. Neuroimmune biology, vol. 6. Amsterdam: Elsevier; 2008. p. 21–38.
42. Buller KM. Central pathways of immunoregulation. In: Berczi I, Arnason BG, editors; Berczi I, series editor. The brain and host defence. Neuroimmune biology, vol. 9. Amsterdam: Elsevier.
43. E Nagy and I Berczi (1978) Immunodeficiency in hypophysectomized rats. Acta Endocrinol 89 530-537.
44. E Nagy and I Berczi (1989) Pituitary dependence of bone marrow function. Br J Haematol 71 457-462.
45. E Nagy and I Berczi (1981) Prolactin and contact sensitivity. Allergy 36 429-431.
46. E Nagy, I Berczi and HG Friesen (1983) Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol 102 351-357.
47. I Berczi, E Nagy, K Kovacs and E Horvath (1981) Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinol 98 506-513.
48. I Berczi, E Nagy, SL Asa and K Kovacs (1983) Pituitary hormones and contact sensitivity in rats. Allergy 38 325-330.
49. I Berczi, E Nagy, RJ Matusik and HG Friesen (1991) Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 146 2201-2206.
50. ND Horseman, W Zhao, E Montecino-Rodrigez, M Tanaka, K Nakashima, SJ Engle, et al. (1997) Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16 6926-6935.
51. C Bole-Feysot, V Goffin, M Edery, N Binart and PA Kelly (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL-receptor knockout mice. Endocrine Rev 19 225-268.
52. SL Kaplan, MM Grumbach, HG Friesen and BH Costom (1972) Thyrotropin-releasing factor (TRF) effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopituitary dwarfism: further evidence for hypophysiotropic hormone deficiencies. J Clin Endocrinol Metab 35 825-830.
53. YN Sinha, CB Salocks and WP Vanderlaan (1975) Pituitary and serum concentrations of prolactin and GH in Snell dwarf mice. Proc Soc Exp Biol Med 150(1), 207-210.
54. RW Pfaffle, O Blankenstein, S Wuller and H Kentrup (1999) Combined pituitary hormone deficiency: role of Pit-1 and Prop-1. Acta Paediatr Suppl 88(433), 33-41.
55. YN Sinha and WP Vanderlaan (1982) Effect on growth of prolactin deficiency induced in infant mice. Endocrinology 110(6), 1871-1878.
56. E Nagy, I Berczi, GE Wren, SL Asa and K Kovacs (1983) Immunomodulation by bromocriptine. Immunopharmacology 6 231-243.
57. E Nagy and I Berczi (1991) Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128 2776-2784.
58. EL Potter and JM Craig (1975) Pathology of the fetus and the infant. 3rd ed. Chicago: Year Book
59. GE DiMattia, B Gellersen, ML Duckworth and HG Friesen (1990) Human prolactin gene expression: the use of an alternative noncoding exon in decidua and the IM-9_P3 lymphoblastoid cell line. J Biol Chem 265 16412-16421.
60. K Watanabe, CA Kessler, CJ Bachurski, Y Kanda, BD Richardson, J Stanek, et al. (2001) Identification of a decidua-specific enhancer on the human prolactin gene with two critical activator protein 1 (AP-1) binding sites. Mol Endocrinol 15(4), 638-653.
61. H Nagafuchi, N Suzuki, A Kaneko, T Asai and T Sakane (1999) Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 26 1890-1900.
62. JL Warren (1999) Type I cytokines, interferons and their receptors. WE Paul (Eds) Fundamental immunology 4th ed. New York: Lippincott-Raven 741-774.
63. J Venkatesh, E Peeva, X Xu and B Diamond (2006) Cutting edge: hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J Immunol 176 3311.
64. H Selye (1965) The mast cells. Reading, MA: Butterworth
65. K Ishizaka and T Ishizaka (1967) Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol 99(6), 1187-1198.
66. A Szentivanyi (1968) The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42 203-232.
67. T Furuno, A Ito, Y Koma, K Watabe, H Yokozaki, J Bienenstock, et al. (2005) The spermatogenic Ig superfamily/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves. J Immunol 174(11), 6934-6942.
68. DM McKay and J Bienenstock (1994) The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 15(11), 533-538.
69. Petho G, Reeh PW. Effects of bradykinin on nociceptors. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2009. p. 135–68.
70. RG Slavin, VW Fischer, EA Levine, CC Tsai and P Winzenburger (1978) A primate model of allergic bronchopulmonary aspergillosis. Int Arch Allergy Appl Immunol 56(4), 325-333.
71. HF Kauffman, F Beaumont, JG de Monchy, HJ Sluiter and K de Vries (1984) Immunologic studies in bronchoalveolar fluid in a patient with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 74(6), 835-840.
72. KC Schuberth, LM Lichtenstein, A Kagey-Sobotka, M Szklo, KA Kwiterovich and MD Valentine (1982) An epidemiologic study of insect allergy in children. I. Characteristics of the disease. J Pediatr 100(4), 546-551.
73. Donaldson LF. Neurogenic mechanisms in arthritis. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2009. p. 211–41.
74. KO De Swert and GF Joos (2010) Role of tachykinins in asthma and allergic disease. I Berczi (Eds) New Insights to Neurimmune Biology Amsterdam: Elsevier 175-190.
75. Ferdinandy P, Jancso G. Capsaicin-sensitive sensory nerves in myocardial ischemiareperfusion injury and ischemic stress adaptation. Role of nitric oxide and calcitonin gene related peptide. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2009. p. 267–88.
76. Green PG. Neurogenic regulation of bradykinin-induced synovitis. In: Jancso G. editor Berczi I, Szentivanyi A, Series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2009. p. 243–65.
77. Holzer P. Role of vagus nerve in afferent signaling and homeostasis during visceral inflammation. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2009. p. 321–38.
78. Dux M, Messlinger K. Neurogenic vascular responses in the dura mater and their relevance to the pathophysiology of headache. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2009. p. 193–209.
79. P Minoretti, C Gazzaruso, CD Vito, E Emanuele, M Bianchi, E Coen, et al. (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer’s disease. Neurosci Lett 391(3), 147-149.